Metabolomic Profiling Delineates Stage‐Associated Metabolic Remodelling in Cardiovascular‐Kidney‐Metabolic Syndrome
Diabetes/Metabolism Research and Reviews · 2026-09 · 42 (6)
DOI: 10.1002/dmrr.70230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 24.09.2026. Verfasst von Xuemei Gong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Metabolomics, Biomarkers, Cardio-Renal Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Program of the National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Aims
Cardiovascular–kidney–metabolic (CKM) syndrome represents an integrated continuum of metabolic, kidney, and cardiovascular abnormalities. However, the stage‐specific metabolic heterogeneity underlying this clinical framework remains incompletely characterised. Materials and Methods We performed plasma metabolomic profiling in 1374 participants from the China Multi‐Ethnic Cohort across CKM stages 0–4. Participants from Chengdu and Chongqing provinces comprised the discovery cohort ( n = 969), whereas those from Yunnan province comprised the validation cohort ( n = 405). Stage‐associated metabolites were identified using prespecified pairwise comparisons with OPLS‐DA and covariate‐adjusted limma analyses. Weighted correlation network analysis identified coordinated metabolic modules. Machine‐learning models were developed to evaluate discrimination of advanced CKM (stages 3–4) using metabolite signatures independent of conventional CKM‐defining variables.
Results
Among 858 endogenous metabolites, 261 unique metabolites were associated with CKM stages, revealing distinct metabolic patterns from early to advanced CKM. Stage 1 was characterised by altered lipid‐ and bile acid‐related metabolites, stage 2 by broader lipid and amino‐acid remodelling, and stage 3 by additional carbohydrate, aromatic amino‐acid, secondary bile acid, host–microbial, and renal‐handling signals. Metabolic separation between stages 3 and 4 was comparatively weak. WGCNA identified a CKM‐associated turquoise module, with γ‐glutamylvaline as a hub metabolite. A model incorporating age, sex, and eight metabolites derived from the discovery cohort showed favourable performance for distinguishing advanced CKM from earlier stages and achieved an AUROC of 0.874 (95% CI, 0.802–0.931) in the validation cohort.
Conclusions
CKM stages exhibit distinct and non‐linear metabolic signatures. A compact metabolomic panel independent of conventional CKM‐defining variables may provide complementary molecular information for advanced CKM phenotyping and future risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China.
- West China Biomedical Big Data Center, West China Hospital of Sichuan University, Chengdu, China.
- Department of Nephrology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.
- School of Public Health, Kunming Medical University, Kunming, China.
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Xuemei Gong, Chunyang Li, Jianzhong Yin, Xing Zhao, Ping Fu, Xiaoxi Zeng
Förderung
- General Program of the National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Gong, X., Li, C., Chen, J., Wang, Y., Tang, W., Zhang, X., Yin, J., Zhao, X., Yu, H., Fu, P., & Zeng, X. (2026). Metabolomic Profiling Delineates Stage‐Associated Metabolic Remodelling in Cardiovascular‐Kidney‐Metabolic Syndrome. Diabetes/Metabolism Research and Reviews, 42(6). https://doi.org/10.1002/dmrr.70230
Vancouver
Gong X, Li C, Chen J, Wang Y, Tang W, Zhang X, et al. Metabolomic Profiling Delineates Stage‐Associated Metabolic Remodelling in Cardiovascular‐Kidney‐Metabolic Syndrome. Diabetes/Metabolism Research and Reviews. 2026;42(6). doi:10.1002/dmrr.70230
BibTeX
@article{Gong2026,
author = {Gong, Xuemei and Li, Chunyang and Chen, Jing and Wang, Yujiao and Tang, Wenge and Zhang, Xuehui and Yin, Jianzhong and Zhao, Xing and Yu, Haopeng and Fu, Ping and Zeng, Xiaoxi},
title = {Metabolomic Profiling Delineates Stage‐Associated Metabolic Remodelling in Cardiovascular‐Kidney‐Metabolic Syndrome},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2026},
volume = {42},
number = {6},
doi = {10.1002/dmrr.70230}
}
EUVIMED